ReviewACS pharmacology & translational science2026
Antimicrobial Systems Based on Essential Oils Advanced by Zinc Oxide Nanoparticles.
Review in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zinc oxide nanoparticles (ZnO NPs) have emerged as a promising material to enhance the performance of essential oils (EOs) in various applications due to their unique properties, including chemical stability, biocompatibility, and antimicrobial efficacy. This review examines the potential of combining ZnO NPs with EOs, focusing on their integration into polymeric matrices for improved antimicrobial effectiveness, stability, and controlled release. The incorporation of ZnO NPs with EOs shows significant promise in fields such as food packaging, medicine, and agriculture, offering a natural alternative to synthetic chemicals. The review addresses key challenges like antimicrobial resistance and highlights ZnO NP's role in overcoming the limitations of EOs, such as low bioavailability and rapid oxidation. Additionally, the potential of these hybrid advanced materials for extending the shelf life of food products, enhancing therapeutic properties, and improving plant disease management is explored. This review provides a comprehensive overview of recent advances, underscoring the potential of ZnO NP and EO systems as advanced materials to address pressing challenges in public health and industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.